Quarterly report pursuant to Section 13 or 15(d)

Revolving Credit Facility and Term Loan

v3.20.1
Revolving Credit Facility and Term Loan
6 Months Ended
Mar. 31, 2020
Revolving Credit Facility and Term Loan  
7. Revolving Credit Facility and Term Loan

Revolving Credit, Term Loan and Security Agreement

 

The Company and its subsidiaries, as borrowers, are parties to a Revolving Credit, Term Loan and Security Agreement (the “Credit Agreement”) with certain investment funds managed by MGG Investment Group LP ("MGG"). The Revolving Credit Facility and Term Loan under the Credit Agreement, as amended, mature on June 30, 2023.

 

Revolving Credit Facility

 

As of March 31, 2020, the Company had $15,015 in outstanding borrowings under the Revolving Credit Facility, of which approximately $14,958 was at an interest rate of approximately 11%, and approximately $57 was at an interest rate of approximately 17.25%.

 

As of March 31, 2020, the Company had approximately $100 available on the Revolving Credit facility.

 

The Revolving Credit Facility is secured by all the Company’s property and assets, whether real or personal, tangible or intangible, and whether now owned or hereafter acquired, or in which it now has or at any time in the future may acquire any right, title or interests.

 

 Term Loan

 

The Company had outstanding balances under its Term Loan, as follows:

 

 

March 31,

2020

 

September 30,

2019

 

Term loan

 

$

41,578

 

$

41,905

 

Unamortized debt discount

 

(806

)

 

(1,208

)

Term loan, net of discount

 

40,772

 

40,697

 

Short term portion of term loan, net of discounts

 

-

 

4,668

 

Long term portion of term loan, net of discounts

 

$

40,772

 

$

36,029

  

The Term Loan is payable as follows, subject to acceleration upon the occurrence of an Event of Default under the Credit Agreement or termination of the Credit Agreement and provided that all unpaid principal, accrued and unpaid interest and all unpaid fees and expenses shall be due and payable in full on June 30, 2023. Principal payments are required as follows: fiscal 2020 – $0, fiscal 2021- $889, fiscal 2022 – $1,779, and fiscal 2023 - $38,910.

 

The Company also was required to prepay the outstanding amount of the Term Loan in an amount equal to the Specified Excess Cash Flow Amount (as defined in the agreement) for the immediately preceding fiscal year, commencing with the fiscal year ending September 30, 2019 (refer to Seventh Amendment to Credit Agreement, below, and Note 15. Subsequent Events.). The Company does not owe any amount as of March 31, 2020.

 

As of March 31, 2020, the Company had $41,578 in outstanding borrowings under the Term Loan that have an annual cash interest rate of approximately 11%, plus additional interest at an annual rate of 5% in the form of PIK (noncash, paid-in-kind), which accrues and is added to the balance of the Term Loan on a monthly basis.

 

The Credit Agreement includes financial and other restrictive covenants. Financial covenants include minimum fixed charge coverage ratios, minimum EBITDA, as defined under the Credit Agreement to include certain adjustments, and a maximum senior leverage ratios. The Company measures and certifies these covenants quarterly. The financial covenants are measured on a trailing four quarter basis as of the end of each quarter. The Company did not meet its financial covenants for the trailing four quarters ended March 31, 2020. The Company received a waiver for missing the March 31, 2020 covenants and its future financial covenants have been reset under the Seventh and Eighth Amendments of the Credit Agreement (refer to Seventh Amendment to Credit Agreement, below, and Note 15. Subsequent Events.).

 

The Credit Agreement also permits capital expenditures up to a certain level and contains customary default and acceleration provisions. The Credit Agreement also restricts, above certain levels, acquisitions, incurrence of additional indebtedness, and payment of dividends.

 

Seventh Amendment to Credit Agreement

 

On April 28, 2020, the Company and its subsidiaries entered into Seventh Amendment, dated as of April 28, 2020 (the "Seventh Amendment"), to the Revolving Credit, Term Loan and Security Agreement, dated as of March 31, 2017 (as amended, amended and restated, restated, supplemented or otherwise modified from time to time, the "Credit Agreement"). The Seventh Amendment represents the most significant loan modification of the Company’s Credit Agreement since inception. The Company and its senior lenders previously entered into the Sixth Amendment on February 12, 2020, while negotiating and in contemplation of the larger loan modification contained in Seventh Amendment. (See Note 15. Subsequent Events.)

  

Eighth Amendment to Credit Agreement and CARES Act Payroll Protection Program Loans

 

On May 5, 2020 the Company and its subsidiaries entered into nine (9) unsecured promissory notes payable under CARES Act Payroll Protection Program (“PPP”) and received net funds totaling $19,926 in order to obtain needed relief funds for allowable expenses under the CARES Act PPP. (See Note 15. Subsequent Events.). On May 5, 2020, the Company also entered into Eighth Amendment, dated as of May 5, 2020 (the "Eighth Amendment") to the Credit Agreement. The Eighth Amendment served as the conforming amendment under the Credit Agreement to enable the Company and its subsidiaries to enter into the PPP loans and additional permitted indebtedness in compliance with the Credit Agreement. (See Note 15. Subsequent Events.)